Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
As more functional redundancy in mammalian cells is discovered, enhanced expression of genes involved in alternative pathways may become an effective form of gene therapy. X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid metabolism. The X-ALD gene encodes a peroxisomal membrane protein (ALDP) that is part of a small family of related peroxisomal membrane proteins. We show that 4-phenylbutyrate treatment of cells from both X-ALD patients and X-ALD knockout mice results in decreased levels of and increased beta-oxidation of very-long-chain fatty acids; increased expression of the peroxisomal protein ALDRP; and induction of peroxisome proliferation. We also demonstrate that ALDP and ALDRP are functionally related, by ALDRP cDNA complementation of X-ALD fibroblasts. Finally, we demonstrate the in vivo efficacy of dietary 4-phenylbutyrate treatment through its production of a substantial reduction of very-long-chain fatty acid levels in the brain and adrenal glands of X-ALD mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dietary treatment with 4PBA in ALD 2 mice has been shown to partially correct the accumulation of VLCFAs in brain and adrenal glands, correlating with ALDR protein induction and increased peroxisome proliferation (27).”
From Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy (2004) · cites this paper as [27]
In the citing paper
“Consistently, the residual peroxisomal β-oxidation of VLCFA is ~20% of normal in X-ALD fibroblasts [150,151] and can be restored by ABCD2 or ABCD3 overexpression [152,153].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [153]
In the citing paper
“Overexpression of ALDRP cDNA in human and mouse X-ALD fibroblasts completely restores VLCFA β-oxidation and results in normal levels of VLCFAs [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“The expression of the ABCD2 gene can be induced pharmacologically both in vitro and in vivo with 4-phenylbutyrate and fenofibrate [Kemp et al., 1998;Netik et al., 1999].”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
In the citing paper
“increasing the expression of an alternate gene (ALDR, ABCD2), which can substitute, at least in part, for the function of ALDP (ABCD1) [Kemp et al., 1998]”
From ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations (2001) · cites this paper as Kemp et al., 1998
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Annals of the New York Academy of Sciences
(2019) · Annals of the New York Academy of Sciences · doi:10.1111/(issn)1749-6632 · Cited by 1,305
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
The metabolic basis of inherited disease
Goldstein, J. L. (1995) · Medical Entomology and Zoology · Cited by 1,009
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., & Davies, K. E. (1996) · Nature · doi:10.1038/384349a0 · Cited by 490
Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy
Moser, H. (1997) · Brain · doi:10.1093/brain/120.8.1485 · Cited by 478
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
Perrine, S. P., Ginder, G. D., Faller, D. V., Dover, G. H., Ikuta, T., Witkowska, H. E., Cai, S.-P., Vichinsky, E. P., & Olivieri, N. F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280202 · Cited by 437
Kamijo, K., Taketani, S., Yokota, S., Osumi, T., & Hashimoto, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39595-x · Cited by 391
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Research works printed but not linked: 1
- Moser, H.W. & Moser, A.B. in Techniques in Diagnostic Biochemical Genetics: A Laboratory Manual (ed. A., H.F.) 177– 191 (Wiley-Liss, New York, 1991).
Cited by
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Biochemistry of mammalian peroxisomes revisited
Wanders, R. J. A., & Waterham, H. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133329 · Cited by 995
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Ten, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2909 · Cited by 350
Kemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. A., & Moser, H. W. (2001) · Human Mutation · doi:10.1002/humu.1227 · Cited by 321
“A novel approach is what has been referred to as pharmacological gene therapy, based upon the concept of increasing the expression of an alternate gene (ALDR, ABCD2), which can substitute, at least in part, for the function of ALDP (ABCD1) [Kemp et al., 1998].”
BackgroundInfluentialSelf-citationShapiro, E., Krivit, W., Lockman, L., Jambaqué, I., Peters, C., Cowan, M., Harris, R., Blanche, S., Bordigoni, P., Loes, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02629-5 · Cited by 329
Life extension in Drosophila by feeding a drug
Kang, H.-L., Benzer, S., & Min, K.-T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022631999 · Cited by 295
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
Adrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Self-citationClinical and Experimental Applications of Sodium Phenylbutyrate
Iannitti, T., & Palmieri, B. (2011) · Drugs in R & D · doi:10.1007/bf03259725 · Cited by 270
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
Andreassi, C., Angelozzi, C., Tiziano, F. D., Vitali, T., De Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201102 · Cited by 255
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238
Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease
Kim, W. S., Weickert, C. S., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05099.x · Cited by 238
Wiese, S., Gronemeyer, T., Ofman, R., Kunze, M., Grou, C. P., Almeida, J. A., Eisenacher, M., Stephan, C., Hayen, H., Schollenberger, L., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700169-mcp200 · Cited by 231
“Interestingly, there is evidence that these ABC transporters show some functional redundancy, providing new possibilities for the treatment of X-ALD patients [41-43].”
BackgroundPujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214
Chiurazzi, P., Grazia Pomponi, M., Pietrobono, R., Bakker, C. E., Neri, G., & Oostra, B. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2317 · Cited by 217
Turk, B. R., Theda, C., Fatemi, A., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 210
Self-citationPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201
Peroxisome Biogenesis Disorders
Weller, S., Gould, S. J., & Valle, D. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110424 · Cited by 203
X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects
Berger, J., & Gärtner, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.010 · Cited by 199
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
Hein, S., Schonfeld, P., Kahlert, S., & Reiser, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn066 · Cited by 180
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170
Self-citationHistone deacetylase inhibitors: possible implications for neurodegenerative disorders
Hahnen, E., Hauke, J., Tränkle, C., Eyüpoglu, I. Y., Wirth, B., & Blümcke, I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.169 · Cited by 165
Function of prokaryotic and eukaryotic ABC proteins in lipid transport
Pohl, A., Devaux, P. F., & Herrmann, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.12.007 · Cited by 170
Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry
Valianpour, F., Selhorst, J. J. M., van Lint, L. E. M., van Gennip, A. H., Wanders, R. J. A., & Kemp, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00098-2 · Cited by 150
Self-citationNetik, A., Forss-Petter, S., Holzinger, A., Molzer, B., Unterrainer, G., & Berger, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.907 · Cited by 148
Genes modulated by histone acetylation as new effectors of butyrate activity
Ragione, F. D., Criniti, V., Pietra, V. D., Borriello, A., Oliva, A., Indaco, S., Yamamoto, T., & Zappia, V. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02539-x · Cited by 169
Role of ALDP (ABCD1) and Mitochondria in X-Linked Adrenoleukodystrophy
McGuinness, M. C., Lu, J.-F., Zhang, H.-P., Dong, G.-X., Heinzer, A. K., Watkins, P. A., Powers, J., & Smith, K. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.744-753.2003 · Cited by 147
Self-citationWiesinger, C., Kunze, M., Regelsberger, G., Forss-Petter, S., & Berger, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445445 · Cited by 145
Homo- and Heterodimerization of Peroxisomal ATP-binding Cassette Half-transporters
Liu, L. X., Janvier, K., Berteaux-Lecellier, V., Cartier, N., Benarous, R., & Aubourg, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32738 · Cited by 141
Berger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Phenylbutyrate Induces Antimicrobial Peptide Expression
Steinmann, J., Halldórsson, S., Agerberth, B., & Gudmundsson, G. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00818-09 · Cited by 144
van Geel, B. M., Assies, J., Haverkort, E. B., Koelman, J. H. T. M., Verbeeten, B., Wanders, R. J. A., & Barth, P. G. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.3.290 · Cited by 131
Transport of fatty acids and metabolites across the peroxisomal membrane
Hettema, E. H., & Tabak, H. F. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00045-7 · Cited by 126
Krivit, W. A., Aubourg, P. R., Shapiro, E., & Peters, C. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199911000-00004 · Cited by 133
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Bastías‐Candia, S., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological Reviews · doi:10.1111/brv.12320 · Cited by 122
The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
Dubois-Dalcq, M., Feigenbaum, V., & Aubourg, P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01319-8 · Cited by 121
Theodoulou, F. L., Holdsworth, M., & Baker, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.095 · Cited by 119
Biochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116
Self-citationKemp, S., Theodoulou, F. L., & Wanders, R. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01435.x · Cited by 115
Self-citationMuntau, A. C., Leandro, J., Staudigl, M., Mayer, F. P., & Gersting, S. W. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9701-z · Cited by 132
Chung, Y., Sheu, M., & Yen, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11303 · Cited by 113
The peroxisomal ABC transporter family
Wanders, R. J. A., Visser, W. F., van Roermund, C. W. T., Kemp, S., & Waterham, H. R. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0142-x · Cited by 129
Self-citationLipid Traffic: The ABC of Transbilayer Movement
Raggers, R. J., Pomorski, T. G., Holthuis, J. C. M., Kälin, N., & Gerrit van, M. E. E. R. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010305.x · Cited by 123
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients
Jang, J., Kang, H., Kim, H., Kim, J. Y., Huh, Y. J., Kim, D., Yoo, J., Lee, J., Lim, B., Lee, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22486 · Cited by 109
Berger, J., Albet, S., Bentejac, M., Netik, A., Holzinger, A., Roscher, A. A., Bugaut, M., & Forss‐Petter, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00772.x · Cited by 106
Chung, Y. L., Wang, A.-J., & Yao, L.-F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.317.3.3 · Cited by 110
Regulation of lifespan by histone deacetylase
Chang, K. T., & Min, K. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00003-x · Cited by 113
Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy
Fourcade, S., Ruíz, M., Guilera, C., Hahnen, E., Brichta, L., Naudí, A., Portero‐Otín, M., Dacremont, G., Cartier, N., Wanders, R. J. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq082 · Cited by 109
Self-citationUpdate on genetic disorders affecting white matter
Kaye, E. M. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(00)00232-0 · Cited by 106
Peroxisomes and cancer: The role of a metabolic specialist in a disease of aberrant metabolism
Dahabieh, M. S., Pietro, E. D., Jangal, M., Gonçalves, C., Witcher, M., Braverman, N., & Rincon, S. V. D. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.004 · Cited by 108
Modelling brain diseases in mice: the challenges of design and analysis
Watase, K., & Zoghbi, H. Y. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1045 · Cited by 108
Novel pharmacologic therapies for cystic fibrosis
Zeitlin, P. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6346 · Cited by 97
Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy
Berger, J., Pujol, A., Aubourg, P. R., & Forss‐Petter, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00393.x · Cited by 102
Infection-Induced Peroxisome Biogenesis Is a Metabolic Strategy for Herpesvirus Replication
Beltran, P. M. J., Cook, K. C., Hashimoto, Y., Galitzine, C., Murray‐Nerger, L. A., Vitek, O., & Cristea, I. M. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.09.002 · Cited by 90
Asheuer, M., Bieche, I., Laurendeau, I., Moser, A., Hainque, B., Vidaud, M., & Aubourg, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi140 · Cited by 86
“The possible functional equivalence of the ABCD1 and ABCD2 genes has been repeatedly suggested (22,23).”
BackgroundSelf-citationPlasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin
Khan, M., Singh, J., & Singh, I. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05513.x · Cited by 95
The ins and outs of peroxisomes: Co-ordination of membrane transport and peroxisomal metabolism
Rottensteiner, H., & Theodoulou, F. L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.012 · Cited by 101
Kemp, S., & Wanders, R. J. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.10.001 · Cited by 82
“[12]: a two day exposure of human Wbroblasts to 4-PBA resulted in a substantial increase in the expression of PEX11 .”
InfluentialSelf-citationABC transporters: human disease and pharmacotherapeutic potential
Moore, J. M., Bell, E. L., Hughes, R. O., & Garfield, A. S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.11.001 · Cited by 101
Redox Signaling from and to Peroxisomes: Progress, Challenges, and Prospects
Fransen, M., & Lismont, C. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7515 · Cited by 107
Progress in X-linked adrenoleukodystrophy
Moser, H. W., Dubey, P., & Fatemi, A. S. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200406000-00005 · Cited by 87
Singh, J., Khan, M., & Singh, I. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800321-jlr200 · Cited by 81
Roth, A. D., Leisewitz, A. V., Jung, J. E., Cassina, P., Barbeito, L., Inestrosa, N. C., & Bronfman, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10596 · Cited by 77
Small Molecules in Development for the Treatment of Spinal Muscular Atrophy
Calder, A. N., Androphy, E. J., & Hodgetts, K. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00670 · Cited by 81
Ciana, P., Biserni, A., Tatangelo, L., Tiveron, C., Sciarroni, A. F., Ottobrini, L., & Maggi, A. C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0152 · Cited by 78
Weber, F. D., Wiesinger, C., Forss-Petter, S., Regelsberger, G., Einwich, A., Weber, W. H. A., Kohler, W., Stockinger, H., & Berger, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt645 · Cited by 63
Fourcade, S., Savary, S., Albet, S., Gauthé, D., Gondcaille, C., Pineau, T., Bellenger, J., Bentejac, M., Holzinger, A., Berger, J., et al. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02249.x · Cited by 70
Hartley, M. D., Kirkemo, L. L., Banerji, T., & Scanlan, T. S. (2017) · Endocrinology · doi:10.1210/en.2016-1842 · Cited by 74
Gondcaille, C., Depreter, M., Fourcade, S., Lecca, M. R., Leclercq, S., Martin, P. G. P., Pineau, T., Cadepond, F., El‐Etr, M., Bertrand, N., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501036 · Cited by 76
Uptake and metabolism of plasma-derived erucic acid by rat brain
Golovko, M. Y., & Murphy, E. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600029-jlr200 · Cited by 73
Pai, G. S., Khan, M., Barbosa, E., Key, L. L., Craver, J. R., Curé, J. K., Betros, R., & Singh, I. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.2977 · Cited by 77
Schönfeld, P., & Reiser, G. (2016) · Aging and disease · doi:10.14336/ad.2015.0823 · Cited by 67
Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal
Lee, J. Y., & Petratos, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0013-1 · Cited by 75
Peroxisomal ABC Transporters: An Update
Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116093 · Cited by 68
Peroxisome homeostasis: Mechanisms of division and selective degradation of peroxisomes in mammals
Honsho, M., Yamashita, S.-I., & Fujiki, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.032 · Cited by 78
Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment*
Berger, J., Moser, H. W., & Forss‐Petter, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200106000-00007 · Cited by 66
Depreter, M., Espeel, M., & Roels, F. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10330 · Cited by 63
X‐linked adrenoleukodystrophy: Therapeutic approaches to distinct phenotypes
Mahmood, A., Dubey, P., Moser, H. W., & Moser, A. B. (2005) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00447.x · Cited by 68
Self-citationCorbett, G. T., Roy, A., & Pahan, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426536 · Cited by 67
Natural history of X-linked adrenoleukodystrophy in Japan
Suzuki, Y., Takemoto, Y., Shimozawa, N., Imanaka, T., Kato, S., Furuya, H., Kaga, M., Kato, K., Hashimoto, N., Onodera, O., et al. (2004) · Brain and Development · doi:10.1016/j.braindev.2004.09.008 · Cited by 64
Epidemiology of X-linked adrenoleukodystrophy in Japan
Takemoto, Y., Suzuki, Y., Tamakoshi, A., Onodera, O., Tsuji, S., Hashimoto, T., Shimozawa, N., Orii, T., & Kondo, N. (2002) · Journal of Human Genetics · doi:10.1007/s100380200090 · Cited by 63
He, B., & Moreau, R. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.002 · Cited by 66
Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division
Itoyama, A., Honsho, M., Abe, Y., Moser, A. B., Yoshida, Y., & Fujiki, Y. (2012) · Journal of Cell Science · doi:10.1242/jcs.087452 · Cited by 65
Self-citationWeinhofer, I. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2701 · Cited by 59
Therapy of X-linked adrenoleukodystrophy
Moser, H. W. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.004 · Cited by 66
Long-Term Treatment with Sodium Phenylbutyrate in Ornithine Transcarbamylase-Deficient Patients
Burlina, A., Ogier, H., Korall, H., & Trefz, F. K. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3156 · Cited by 58
Gloeckner, C. J., Mayerhofer, P. U., Landgraf, P., Muntau, A. C., Holzinger, A., Gerber, J.-K., Kammerer, S., Adamski, J., & Roscher, A. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2572 · Cited by 57
Colton, H. M., Falls, J. G., Ni, H., Kwanyuen, P., Creech, D., McNeil, E., Casey, W., Hamilton, G. A., & Cariello, N. F. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh144 · Cited by 54
Chung, Y., Lee, M.-Y., & Pui, N. N. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp079 · Cited by 56
Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked Adrenoleukodystrophy
McGuinness, M. C., Zhang, H.-P., & Smith, K. D. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3239 · Cited by 51
Self-citationCharacterization of the human ω‐oxidation pathway for ω‐hydroxy‐very‐long‐chain fatty acids
Sanders, R., Ofman, R., Dacremont, G., Wanders, R. J. A., & Kemp, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-099150 · Cited by 59
Self-citationBaarine, M., Ragot, K., Genin, E. C., El Hajj, H., Trompier, D., Andreoletti, P., Ghandour, M. S., Menetrier, F., Cherkaoui‐Malki, M., Savary, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06311.x · Cited by 51
Flavigny, E., Sanhaj, A., Aubourg, P. R., & Cartier, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00379-8 · Cited by 54
Engelen, M., Schackmann, M. J. A., Ofman, R., Sanders, R., Dijkstra, I. M. E., Houten, S. M., Fourcade, S., Pujol, A., Poll‐The, B. T., Wanders, R. J. A., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9471-4 · Cited by 55
Self-citationBaarine, M., Beeson, C., Singh, A. K., & Singh, I. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12992 · Cited by 52
Activation of the stress proteome as a mechanism for small molecule therapeutics
Brose, R. D., Shin, G., McGuinness, M. C., Schneidereith, T., Purvis, S. H., Dong, G.-X., Keefer, J. R., Spencer, F. A., & Smith, K. D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds247 · Cited by 47
Self-citationZhang, X., De Marcos Lousa, C., Schutte-Lensink, N., Ofman, R., Wanders, R. J., Baldwin, S. A., Baker, A., Kemp, S., & Theodoulou, F. L. (2011) · Biochemical Journal · doi:10.1042/bj20110249 · Cited by 43
“The apparent delay in alteration of VLCFA levels reflects slow turnover of VLCFA in fibroblasts, as demonstrated previously in a study in which the pharmacological agent 4phenylbutyrate was used to correct -oxidation and VLCFA levels in X-ALD cells [57].”
BackgroundSelf-citation
Metadata
- Authors
- Kemp, S., Wei, H.-M., Lu, J.-F., Braiterman, L. T., McGuinness, M. C., Moser, A. B., Watkins, P. A., & Smith, K. D.
- Affiliations
- Kennedy Krieger Institute (US)
- Corresponding author
- Smith, Kirby D.
- Venue
- Nature Medicine
- Published
- 1998-11
- Volume
- 4
- Issue
- 11
- Pages
- 1261-1268
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/3242
- OpenAlex
- W2035026471
- Cited by
- 249
- References
- 57
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health (1r01dk051149-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK51149)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD24061, HD-10981, P30HD024061, P01HD010981)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- X-linked adrenoleukodystrophy, gene redundancy, 4-phenylbutyric acid, peroxisomal membrane proteins, ALDP, very long chain fatty acids, fatty acid beta-oxidation, peroxisome proliferation, peroxisomal disorders, dietary therapy
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Animals, Cell Line, Cells, Cultured, Fibroblasts, Multigene Family, Humans, Lymphocytes, Microbodies, Phenylbutyrates, Proteins, X Chromosome, Genetic Therapy, DNA Primers, Mice, Knockout, ATP-Binding Cassette Transporters, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.